AbstractDrug induced lung diseases (DILD) are an increasingly cause of morbidity. Many drugs have been described, causing several patterns of injury. Sirolimus is an immunosuppressive agent increasingly used in renal and other solid organ transplantation. Pulmonary toxicity has been recognised as a potential complication associated to this medication. Interstitial pneumonitis and more rarely alveolar haemorrhage have been described. The authors describe 4 cases (3 men and 1 woman) between 46-71 years, transplanted three years ago (1 patient) and 7 years ago (3 patients). All of them were medicated with micofenolato mofetil, prednisone and sirolimus. All patients had fever at admission, 3 patients had dyspnoea and 2 productive cough. Diffuse...
Everolimus has important clinical activity in various malignancies, but its use can be complicated b...
AbstractDrug-induced interstitial lung disease is associated with significant morbidity and mortalit...
The mTOR inhibitors (mTORi, mammalian target of rapamycin; sirolimus and everolimus) have been recen...
As doenças pulmonares induzidas por fármacos constituem uma causa crescente de morbilidade, tendo si...
AbstractObjectivesReport a case of sirolimus induced granulomatous pneumonitis.BackgroundSirolimus i...
AbstractDrug induced lung diseases (DILD) are an increasingly cause of morbidity. Many drugs have be...
Resumo: As doenças pulmonares induzidas por fármacos constituem uma causa crescente de morbilidade...
Transpl Int. 2007 Mar;20(3):291-6. Pulmonary alveolar proteinosis: a rare pulmonary toxicity of s...
International audienceIntroductionSirolimus is an immunosupressant used in renal transplantation bec...
The use of inhibitors of the mammalian target of rapamycin (mTORi) in renal transplantation is assoc...
PURPOSE: Sirolimus is a potent immunosuppressive agent used with increasing frequency in kidney tran...
The use of inhibitors of the mammalian target of rapamycin (mTORi) in renal transplantation is assoc...
Sirolimus-associated pneumonitis, a rare but serious drug-induced lung injury, has become a great co...
Background Kidney transplant recipients are at higher risk of developing pulmonary complications rel...
AbstractLike sirolimus, everolimus is an inhibitor of mTOR (mammalian target of rapamycin), used as ...
Everolimus has important clinical activity in various malignancies, but its use can be complicated b...
AbstractDrug-induced interstitial lung disease is associated with significant morbidity and mortalit...
The mTOR inhibitors (mTORi, mammalian target of rapamycin; sirolimus and everolimus) have been recen...
As doenças pulmonares induzidas por fármacos constituem uma causa crescente de morbilidade, tendo si...
AbstractObjectivesReport a case of sirolimus induced granulomatous pneumonitis.BackgroundSirolimus i...
AbstractDrug induced lung diseases (DILD) are an increasingly cause of morbidity. Many drugs have be...
Resumo: As doenças pulmonares induzidas por fármacos constituem uma causa crescente de morbilidade...
Transpl Int. 2007 Mar;20(3):291-6. Pulmonary alveolar proteinosis: a rare pulmonary toxicity of s...
International audienceIntroductionSirolimus is an immunosupressant used in renal transplantation bec...
The use of inhibitors of the mammalian target of rapamycin (mTORi) in renal transplantation is assoc...
PURPOSE: Sirolimus is a potent immunosuppressive agent used with increasing frequency in kidney tran...
The use of inhibitors of the mammalian target of rapamycin (mTORi) in renal transplantation is assoc...
Sirolimus-associated pneumonitis, a rare but serious drug-induced lung injury, has become a great co...
Background Kidney transplant recipients are at higher risk of developing pulmonary complications rel...
AbstractLike sirolimus, everolimus is an inhibitor of mTOR (mammalian target of rapamycin), used as ...
Everolimus has important clinical activity in various malignancies, but its use can be complicated b...
AbstractDrug-induced interstitial lung disease is associated with significant morbidity and mortalit...
The mTOR inhibitors (mTORi, mammalian target of rapamycin; sirolimus and everolimus) have been recen...